The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
The Role of Inflammatory Cytokines in Diabetic Nephropathy
Abstract
Cytokines act as pleiotropic polypeptides regulating inflammatory and immune responses through actions on cells. They provide important signals in the pathophysiology of a range of diseases, including diabetes mellitus. Chronic low-grade inflammation and activation of the innate immune system are closely involved in the pathogenesis of diabetes and its microvascular complications. Inflammatory cytokines, mainly IL-1, IL-6, and IL-18, as well as TNF-alpha, are involved in the development and progression of diabetic nephropathy. In this context, cytokine genetics is of special interest to combinatorial polymorphisms among cytokine genes, their functional variations, and general susceptibility to diabetic nephropathy. Finally, the recognition of these molecules as significant pathogenic mediators in diabetic nephropathy leaves open the possibility of new potential therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Inflammation: the link between insulin resistance, obesity and diabetes
Dandona, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.10.013 · Cited by 2,170
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414
The Global Burden of Chronic Diseases: Overcoming Impediments to Prevention and Control
Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004) · JAMA · doi:10.1001/jama.291.21.2616 · Cited by 1,369
Thomson, A. W. (1994) · Cited by 1,116
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I., Tracy, R. P., & Heiss, G. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,071
Biological and clinical aspects of interleukin 6
Hirano, T., Akira, S., Taga, T., & Kishimoto, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90173-7 · Cited by 1,066
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Pro-inflammatory cytokines and adipose tissue
Coppack, S. W. (2001) · Proceedings of the Nutrition Society · doi:10.1079/pns2001110 · Cited by 1,006
Familial Clustering of Diabetic Kidney Disease
Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905043201801 · Cited by 994
Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.
Laster, S. M., Wood, J. G., & Gooding, L. R. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.8.2629 · Cited by 903
Cytokine gene polymorphism in human disease: on-line databases
Bidwell, J., Keen, L., Gallagher, G., Kimberly, R., Huizinga, T., McDermott, M., Oksenberg, J., McNicholl, J., Pociot, F., Hardt, C., et al. (1999) · Genes & Immunity · doi:10.1038/sj.gene.6363645 · Cited by 812
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
Balkwill, F. R., & Burke, F. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90085-6 · Cited by 783
Pathogenetic Mechanisms of Diabetic Nephropathy
Schena, F. P., & Gesualdo, L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110970 · Cited by 589
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Han, J., Thompson, P., & Beutler, B. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.391 · Cited by 508
Beaglehole, R., & Yach, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14335-8 · Cited by 487
Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., Rollin, B. J., & Tesch, G. H. (2006) · Kidney International · doi:10.1038/sj.ki.5000014 · Cited by 440
Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., et al. (2006) · Diabetes · doi:10.2337/db06-0477 · Cited by 419
Demircan, N., Safran, B. G., Soylu, M., Ozcan, A. A., & Sizmaz, S. (2006) · Eye · doi:10.1038/sj.eye.6702138 · Cited by 395
Wójciak-Stothard, B., Entwistle, A., Garg, R., & Ridley, A. J. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<150::aid-jcp17>3.0.co;2-b · Cited by 394
Dandona, P., Dhindsa, S., Ghanim, H., & Chaudhuri, A. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002101 · Cited by 386
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Jeffcoate, W. J., Game, F., & Cavanagh, P. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67029-8 · Cited by 373
Dong, X., Swaminathan, S., Bachman, L.-A., Croatt, A.-J., Nath, K.-A., & Griffin, M.-D. (2007) · Kidney International · doi:10.1038/sj.ki.5002132 · Cited by 363
Melnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.
Sassy-Prigent, C., Heudes, D., Mandet, C., Bélair, M. F., Michel, O., Perdereau, B., Bariéty, J., & Bruneval, P. (2000) · Diabetes · doi:10.2337/diabetes.49.3.466 · Cited by 328
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
Zhang, B., Ramesh, G., Norbury, C. C., & Reeves, W. B. (2007) · Kidney International · doi:10.1038/sj.ki.5002242 · Cited by 309
mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats
Nakamura, T., Fukui, M., Ebihara, I., Osada, S., Nagaoka, I., Tomino, Y., & Koide, H. (1993) · Diabetes · doi:10.2337/diab.42.3.450 · Cited by 307
Pentoxifylline suppression of tumor necrosis factor gene transcription.
Doherty, G. M., Jensen, J. C., Alexander, H. R., Buresh, C. M., & Norton, J. A. (1991) · PubMed · Cited by 306
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Okada, S., Shikata, K., Matsuda, M., Ogawa, D., Usui, H., Kido, Y., Nagase, R., Wada, J., Shikata, Y., & Makino, H. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2586 · Cited by 298
Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells
Radeke, H. H., Meier, B., Topley, N., Flöge, J., Habermehl, G. G., & Resch, K. (1990) · Kidney International · doi:10.1038/ki.1990.44 · Cited by 279
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., & Tesch, G. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070612 · Cited by 277
Moriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy
Hasegawa, G., Nakano, K., Sawada, M., Uno, K., Shibayama, Y., Ienaga, K., & Kondo, M. (1991) · Kidney International · doi:10.1038/ki.1991.308 · Cited by 268
Tumor necrosis factor induces glomerular damage in the rabbit.
Bertani, T., Abbate, M., Zoja, C., Corna, D., Perico, N., Ghezzi, P., & Remuzzi, G. (1989) · Europe PMC (PubMed Central) · Cited by 246
Navarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238
Thomson, S. C., Deng, A., Bao, D., Satriano, J., Blantz, R. C., & Vallon, V. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10963 · Cited by 236
Adipokines, inflammation, and the endothelium in diabetes
Aldhahi, W., & Hamdy, O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0020-2 · Cited by 232
McCarthy, E. T., Sharma, R., Sharma, M., Li, J. Z., Ge, X. L., Dileepan, K. N., & Savin, V. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93433 · Cited by 231
Leukocyte adhesion molecules and kidney diseases
Brady, H. R. (1994) · Kidney International · doi:10.1038/ki.1994.169 · Cited by 230
Role of inflammation in diabetic complications
Navarro, J. F., & Mora, C. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi155 · Cited by 227
Navarro, J. F., Milena, F. J., Mora, C., León, C., & García, J. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Cytokine gene polymorphism in human disease: on-line databases, Supplement 3
Hollegaard, M. V., & Bidwell, J. L. (2006) · Genes & Immunity · doi:10.1038/sj.gene.6364301 · Cited by 219
Nakamura, A., Shikata, K., Hiramatsu, M., Nakatou, T., Kitamura, T., Wada, J., Itoshima, T., & Makino, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2890 · Cited by 218
Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammatory Disease
Tuttle, K. R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040393 · Cited by 216
Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini, R., Velussi, M., Brocco, E., Bruseghin, M., Abaterusso, C., Saller, A., Dalla Vestra, M., Carraro, A., Bortoloso, E., Sambataro, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.476 · Cited by 202
Boyle, J. J., Weissberg, P. L., & Bennett, M. R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000086961.44581.b7 · Cited by 197
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., de Lourdes Noronha, I., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 196
Interleukin 6 is an autocrine growth factor for mesangial cells
Ruef, C., Budde, K., Lacy, J., Northemann, W., Baumann, M., Sterzel, R. B., & Coleman, D. L. (1990) · Kidney International · doi:10.1038/ki.1990.193 · Cited by 194
Cheng, H.-F., Wang, C. J., Moeckel, G. W., Zhang, M.-Z., Mckanna, J. A., & Harris, R. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00520.x · Cited by 193
Pfeilschifter, J., Pignat, W., Vosbeck, K., & Märki, F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90003-x · Cited by 191
IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor
Fantuzzi, G., Reed, D. A., & Dinarello, C. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7501 · Cited by 189
Inflammation and diabetic nephropathy
Mora, C., & Navarro, J. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0080-1 · Cited by 183
Type 2 diabetes mellitus: a disease of the innate immune system? An update
Crook, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01030.x · Cited by 179
In Situ Hybridization of Interleukin 6 in Diabetic Nephropathy
Suzuki, D., Miyazaki, M., Naka, R., Koji, T., Yagame, M., Jinde, K., Endoh, M., Nomoto, Y., & Sakai, H. (1995) · Diabetes · doi:10.2337/diab.44.10.1233 · Cited by 175
Han, S.-Y., Kim, C.-H., Kim, H.-S., Jee, Y.-H., Song, H.-K., Lee, M.-H., Han, K.-H., Kim, H.-K., Kang, Y.-S., Han, J.-Y., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005111196 · Cited by 172
Inflammatory mechanisms of diabetic complications
Williams, M. D., & Nadler, J. L. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0038-y · Cited by 170
Prevention of End-Stage Renal Disease Due to Type 2 Diabetes
Hostetter, T. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451209 · Cited by 169
Kalantarinia, K., Awad, A. S., & Siragy, H. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00237.x · Cited by 156
Stimulated kidney tubular epithelial cells express membrane associated and secreted TNFα
Jevnikar, A. M., Brennan, D. C., Singer, G. G., Heng, J. E., Maslinski, W., Wuthrich, R. P., Glimcher, L. H., & Kelley, V. E. (1991) · Kidney International · doi:10.1038/ki.1991.201 · Cited by 154
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes
DiPetrillo, K., Coutermarsh, B., & Gesek, F. A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00026.2002 · Cited by 154
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., & Makino, H. (1999) · Diabetologia · doi:10.1007/s001250051241 · Cited by 152
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus
Blakemore, A. I. F., Cox, A., González, A.-M., Maskill, J. K., Hughes, M. E., Wilson, R. M., Ward, J. D., & Duff, G. W. (1996) · Human Genetics · doi:10.1007/bf02185776 · Cited by 151
Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & García, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 144
Self-citationNavarro‐González, J. F., Fernández, C. M., Rivero, A., Gallego, E., Chahin, J., Macia, M. L., Méndez, M. L., & García, J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70182-4 · Cited by 143
Self-citationNavarro‐González, J. F., Fernández, C. M., Muros, M., & García, J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl469 · Cited by 140
Self-citationPark, C. W., Kim, J., Lee, J. W., Kim, Y. S., Ahn, H. J., Shin, Y. S., Kim, S.-Y., Choi, E. J., Chang, Y. S., & Bang, B. K. (2000) · Diabetologia · doi:10.1007/s001250051567 · Cited by 138
Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus
Langefeld, C. D., Beck, S. R., Bowden, D. W., Rich, S. S., Wagenknecht, L. E., & Freedman, B. I. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.12.043 · Cited by 137
Interleukin-6: An autocrine regulator of mesangial cell growth
COLEMAN, D. L., & Ruef, C. (1992) · Kidney International · doi:10.1038/ki.1992.91 · Cited by 137
Inflammation and Insulin Resistance
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1922 · Cited by 136
Nakagawa, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2006 · Cited by 134
Elder, M. (1997) · KARGER eBooks · doi:10.1159/000060714 · Cited by 127
Kitamura, A., Hasegawa, G., Obayashi, H., Kamiuchi, K., Ishii, M., Yano, M., Tanaka, T., Yamaguchi, M., Shigeta, H., Ogata, M., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00844.x · Cited by 125
Navarro‐González, J. F., Mora, C., Muros, M., & Garcı́a, J. G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010001 · Cited by 121
Self-citationWong, C. K., Ho, A. M. ‐., Tong, P. C. Y., Yeung, C. Y., Kong, A. P. S., Lun, S. W., Chan, J. C. N., & Lam, C. W. K. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03389.x · Cited by 116
Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats
Moriwaki, Y., Inokuchi, T., Yamamoto, A., Ka, T., Tsutsumi, Z., Takahashi, S., & Yamamoto, T. (2007) · Acta Diabetologica · doi:10.1007/s00592-007-0007-6 · Cited by 110
Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110
Skundric, D. S., & Lisak, R. P. (2003) · Journal of Diabetes Research · doi:10.1155/edr.2003.303 · Cited by 110
Baud, L., Perez, J., Friedlander, G., & Ardaillou, R. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80543-x · Cited by 105
Jones, S. G., Jones, S., & Phillips, A. O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051739.x · Cited by 104
Koike, N., Takamura, T., & Kaneko, S. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.001 · Cited by 103
Detection of Serum IL-6 in Patients with Diabetic Nephropathy
Sekizuka, K., Tomino, Y., Sei, C., Kurusu, A., Tashiro, K., Yamaguchi, Y., Kodera, S., Hishiki, T., Shirato, I., & Koide, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188281 · Cited by 98
Protective Effects of Angiotensin II Interruption: Evidence for Antiinflammatory Actions
Dagenais, N. J., & Jamali, F. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1213 · Cited by 98
Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs.
Fioretto, P., Steffes, M. W., Barbosa, J., Rich, S. S., Miller, M., & Mauer, M. S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.865 · Cited by 98
Cytokine gene polymorphism and progression of renal and cardiovascular diseases
Rao, M., Wong, C. S., Kanetsky, P. A., Girndt, M., Stenvinkel, P., Reilly, M. P., & Raj, D. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002391 · Cited by 97
Cooper, A. C., Mikhail, A. I., Lethbridge, M. W., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000131523.17045.56 · Cited by 95
Dai, S., Matsuno, H., Nakamura, H., Nishioka, K., & Yudoh, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20064 · Cited by 89
DiPetrillo, K., & Gesek, F. A. (2004) · American Journal of Nephrology · doi:10.1159/000079121 · Cited by 87
Wang, X., Feuerstein, G., Xu, L., Wang, H., Schumacher, W. A., Ogletree, M. L., Taub, R. A., Duan, J. J. ‐., Decicco, C. P., & Liu, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.4.890 · Cited by 83
Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians
Wolford, J. K. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.07.003 · Cited by 76
Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes
Placha, G., Canani, L. H. S., Warram, J. H., & Królewski, A. S. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.02.002 · Cited by 72
Differential effect of IL-18 on endothelial cell apoptosis mediated by TNF-α and Fas (CD95)
Mariño, E., & Cardier, J. E. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00150-9 · Cited by 70
Ortíz, A., Bustos, C., Alonso, J., Alcázar, R., López-Armada, M. J., Plaza, J. J. G., González, E. M., & Egido, J. (1995) · PubMed · Cited by 70
Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.
Guerrero‐Romero, F., Rodríguez‐Morán, M., Paniagua-Sierra, J. R., García-Bulnes, G., Salas-Ramírez, M., & Amato, D. (1995) · PubMed · Cited by 65
Stuyt, R. J. L., Netea, M. G., Geijtenbeek, T. B. H., Kullberg, B. J., Dinarello, C. A., & van der Meer, J. W. M. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01747.x · Cited by 64
Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats
Voisin, L., Breuillé, D., Ruot, B., Rallière, C., Rambourdin, F., Dalle, M., & Obled, C. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.5.r1412 · Cited by 64
Genetics of Diabetes and Its Complications
Rich, S. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070770 · Cited by 62
Mahadevan, P., Larkins, R. G., Fraser, J. R. E., Fosang, A., & Dunlop, M. (1995) · Diabetologia · doi:10.1007/bf00400634 · Cited by 60
Wang, H., Zhang, Z., Chu, W. S., Hale, T. C., Cooper, J. J., & Elbein, S. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1606 · Cited by 59
Komers, R., Lindsley, J. N., Oyama, T., & Anderson, S. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04534.x · Cited by 58
Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes
Schreiner, G. F., & Kohan, D. E. (1990) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1990.258.4.f761 · Cited by 58
Role of Macrophages in the Pathogenesis of Diabetic Nephropathy
Shikata, K., & Makino, H. (2001) · KARGER eBooks · doi:10.1159/000060147 · Cited by 53
Lee, S., Lee, T. W., Ihm, C., Kim, M. J., WOO, J., & CHUNG, J. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00454.x · Cited by 45
Rodríguez‐Morán, M., González-González, G. M., Bermúdez-Barba, M. V., Garza, C., Tamez-Pérez, H. E., Martínez-Martínez, F. J., & Guerrero‐Romero, F. (2006) · Clinical Nephrology · doi:10.5414/cnp66003 · Cited by 45
IFNγ induces functional chemokine receptor expression in human mesangial cells
Schwarz, M., WAHL, M., Resch, K., & Radeke, H. H. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01829.x · Cited by 40
Aminorroaya, A., Janghorbani, M., Rezvanian, H., Aminian, T., Manouchehr, G., & Amini, M. (2005) · Nephron Clinical Practice · doi:10.1159/000083417 · Cited by 36
CHAPTER 1 – The cytokines: an overview
Vilcek, J. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50005-3 · Cited by 34
Genetics of diabetes complications
Bowden, D. W. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0080-8 · Cited by 34
Flyvbjerg, A., Khatir, D. S., Jensen, L., Dagnæs‐Hansen, F., Grønbæk, H., & Rasch, R. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383106 · Cited by 34
The next generation of diabetic nephropathy therapies: An update
Williams, M. E., & Tuttle, K. R. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2005.01.011 · Cited by 30
Hyperfiltration, nitric oxide, and diabetic nephropathy
Levine, D. Z. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0012-0 · Cited by 29
Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2005) · Clinical Nephrology · doi:10.5414/cnp64091 · Cited by 29
Pfeilschifter, J., & Mühl, H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90371-s · Cited by 26
Toward a Mouse Model of Diabetic Nephropathy: Is Endothelial Nitric Oxide Synthase the Missing Link?
Quaggin, S. E., & Coffman, T. M. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121396 · Cited by 26
Agents in development for the treatment of diabetic nephropathy
Goh, S., Jasik, M., & Cooper, M. E. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.3.447 · Cited by 24
Monocyte chemotactic peptide-1 in diabetic nephropathy.
Ihm, C. G. (1997) · PubMed · Cited by 21
Agents in development for the treatment of diabetic nephropathy
Fukami, K., Cooper, M. E., & Forbes, J. M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.3.279 · Cited by 18
Diabetes and the global burden of non-communicable disease
Matthews, D. R., & Pramming, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14877-5 · Cited by 12
Emerging drugs for diabetic nephropathy
Bruno, S., Cattaneo, D., Perico, N., & Remuzzi, G. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.4.747 · Cited by 11
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
“Circulating concentrations of TNF- are elevated in individuals with either type 1 or type 2 diabetes compared with healthy control subjects (323, 418).”
BackgroundInflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
Self-citationBala, N., Saha, S., Chakraborty, M., Maiti, M., Das, S., Basu, R., & Nandy, P. (2015) · RSC Advances · doi:10.1039/c4ra12784f · Cited by 743
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Metadata
- Authors
- Navarro-González, J. F., & Mora-Fernández, C.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-03
- Volume
- 19
- Issue
- 3
- Pages
- 433-442
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2108192985
- Cited by
- 932
- References
- 128
- FWCI
- 23.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.